Biohaven pharmaceuticals reports first quarter 2020 financial results and recent business developments

Biohaven pharmaceuticals reports first quarter 2020 financial results and recent business developments.q1 adjusted non-gaap loss per share $2.39.q1 earnings per share estimate $-2.34 -- refinitiv ibes data.q1 loss per share $3.07.

BHVN Ratings Summary

BHVN Quant Ranking